Ardent Health reported third-quarter revenue of $1.62 billion and net income attributable to the company of $45 million, or $0.31 per diluted share. Adjusted EBITDA reached $138 million, driven by a 2.9% increase in adjusted admissions and operational efficiencies from its IMPACT program. The company raised its full-year 2026 adjusted EBITDA guidance midpoint to $517.5 million from $510 million, while maintaining the total revenue outlook of $6.4 billion to $6.7 billion. Additionally, the board authorized a $25 million increase to the share repurchase program, bringing remaining authorization to approximately $48 million. Ardent Health operates 30 acute care hospitals and more than 280 sites of care across six U.S. states.
